| Identification | Back Directory | [Name]
Lifibrol | [CAS]
96609-16-4 | [Synonyms]
K-12148
U 83860
U-83860
K-12.148
Lifibrol
4-[4-[4-(tert-Butyl)phenyl]-2-hydroxybutoxy]benzoic acid
4-[4-[4-(1,1-Dimethylethyl)phenyl]-2-hydroxybutoxy]benzoic acid | [Molecular Formula]
C21H26O4 | [MDL Number]
MFCD00865714 | [MOL File]
96609-16-4.mol | [Molecular Weight]
342.43 |
| Chemical Properties | Back Directory | [Boiling point ]
536.8±45.0 °C(Predicted) | [density ]
1.138±0.06 g/cm3(Predicted) | [pka]
4.43±0.10(Predicted) | [Water Solubility ]
366.4ug/L(29 ºC) |
| Hazard Information | Back Directory | [Uses]
Hypocholesterolemic. | [Definition]
ChEBI: Lifibrol is an alkylbenzene. | [in vivo]
Lifibrol (15, 50 mg/kg; p.o.; daily for 6 days) decreases the plasma total cholesterol[2]. | Animal Model: | Male TUC-Sprague-Dawley rats[2] | | Dosage: | 15, 50 mg/kg | | Administration: | P.o; daily for 6 days | | Result: | Decreased the plasma total cholesterol. |
|
|
| Company Name: |
Leancare Ltd.
|
| Tel: |
+33 962096793 |
| Website: |
www.leancare.co.uk |
|